Justin Squyres
Family Medicine · Clifton, TXNPI 1932410776
Payments from drug & device makers
Across 150 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$649
- Lilly USA, LLC$308
- Bayer$246
- Amgen$203
- AbbVie$140
- Boehringer Ingelheim$96
- plus $764 from 15 others
What the payments were for
- Food & beverage$2,37299%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $649 |
| Lilly USA, LLC | 21 | $308 |
| Bayer | 18 | $246 |
| Amgen | 12 | $203 |
| AbbVie(2 entities) | 7 | $140 |
| Boehringer Ingelheim | 6 | $96 |
| Amarin Pharma, Inc. | 6 | $95 |
| AstraZeneca | 5 | $92 |
| Pfizer | 6 | $90 |
| Merck | 4 | $83 |
| GSK | 5 | $83 |
| Johnson & Johnson | 5 | $73 |
| Biogen | 4 | $69 |
| Dexcom, Inc. | 4 | $56 |
| Novartis | 2 | $34 |
| Abbott | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Edwards Lifesciences | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,405 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 263 | $301,475 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $75,322 |
| EliquisApixaban | 112 | $72,027 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 77 | $59,606 |
| JardianceEmpagliflozin | 76 | $57,962 |
| MounjaroTirzepatide | 49 | $48,853 |
| MyrbetriqMirabegron | 99 | $47,492 |
| XareltoRivaroxaban | 66 | $40,614 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 69 | $21,128 |
| RidauraAuranofin | 12 | $19,442 |
| LinzessLinaclotide | 33 | $19,022 |
| FarxigaDapagliflozin Propanediol | 20 | $17,734 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $17,172 |
| RybelsusSemaglutide | 14 | $13,317 |
| JanuviaSitagliptin Phosphate | 16 | $12,742 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $649 | $314,792277 claims |
| PfizerEliquis, Abrysvo | $90 | $93,155181 claims |
| GSKTrelegy Ellipta, Shingrix, Breo Ellipta | $83 | $72,995128 claims |
| Lilly USA, LLCMounjaro, Trulicity | $308 | $59,50660 claims |
| Boehringer IngelheimJardiance | $96 | $57,96276 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $47,49299 claims |
| Johnson & JohnsonXarelto | $73 | $40,61466 claims |
| AbbVieLinzess | $140 | $19,02233 claims |
| AstraZenecaFarxiga | $92 | $17,73420 claims |
| MerckJanuvia, Belsomra | $83 | $17,66227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Clifton
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.